EUVIMEDEUVIMED entdecken
Crossref

Mismatch Repair Status in Colorectal Carcinoma: A Retrospective Observational Study with Comparative Insights into MMR and MSI Testing

Madan K, Noor Mohammed, Loretta Ann Pereira, Yengkhom Daniel Singh, Sruthi MK, Malathi M, Tejesh Krishna

International Journal of Drug Delivery Technology · 06.06.2026 · 16 (47s)

DOI: 10.25258/ijddt.16.47s.66 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, erschienen am 06.06.2026. Verfasst von Madan K und 6 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Mismatch repair (MMR) deficiency and microsatellite instability (MSI) are crucial biomarkers in colorectal carcinoma (CRC), with prognostic and therapeutic implications. This study aimed to evaluate the prevalence of MMR deficiency and its association with clinicopathological parameters in CRC.

Methods

A retrospective observational study was conducted over a period of two years (January 2024–December 2025) in a tertiary cancer centre. A total of 56 cases of CRC that underwent MMR testing were included. Histopathological parameters and clinical details were analysed. MMR by immunohistochemistry for MLH1, PMS2, MSH2, and MSH6 was performed, and cases were categorised as MMR-proficient (pMMR) or deficient (dMMR). Selective cases underwent further molecular analysis by NGS.

Results

Among the 55 evaluable cases, 13 (23.63%) demonstrated dMMR status, while 42 (76.36%) were pMMR. The most common deficiency pattern was MLH1/PMS2 loss (38.46%). dMMR was more frequently observed in patients ≤50 years and was associated with a higher number of tumour-infiltrating lymphocytes than pMMR cases. Molecular analysis in two of the cases identified pathogenic germline mutations in MLH1 and APC, indicating an association with Lynch syndrome and Familial Adenomatous Polyposis, respectively.

Conclusion

MMR-deficient colorectal carcinoma is a distinct group with characteristic clinicopathological features. IHC remains a practical screening tool, while orthogonal molecular testing improves diagnostic precision. Integration of MMR/MSI testing in routine practice, through universal testing, is crucial for identifying hereditary syndromes and optimising targeted and immunotherapeutic management.

Zitieren

APA

K, M., Mohammed, N., Pereira, L. A., Singh, Y. D., MK, S., M, M., & Krishna, T. (2026). Mismatch Repair Status in Colorectal Carcinoma: A Retrospective Observational Study with Comparative Insights into MMR and MSI Testing. International Journal of Drug Delivery Technology, 16(47s). https://doi.org/10.25258/ijddt.16.47s.66

Vancouver

K M, Mohammed N, Pereira LA, Singh YD, MK S, M M, et al. Mismatch Repair Status in Colorectal Carcinoma: A Retrospective Observational Study with Comparative Insights into MMR and MSI Testing. International Journal of Drug Delivery Technology. 2026;16(47s). doi:10.25258/ijddt.16.47s.66

BibTeX
@article{K2026,
  author = {K, Madan and Mohammed, Noor and Pereira, Loretta Ann and Singh, Yengkhom Daniel and MK, Sruthi and M, Malathi and Krishna, Tejesh},
  title = {Mismatch Repair Status in Colorectal Carcinoma: A Retrospective Observational Study with Comparative Insights into MMR and MSI Testing},
  journal = {International Journal of Drug Delivery Technology},
  year = {2026},
  volume = {16},
  number = {47s},
  doi = {10.25258/ijddt.16.47s.66}
}
Kostenlos starten →